Abiopharma

🔍 Ireland Drew (Executive)

Company: FrontView REIT, Inc. (FVR)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 5,592 shares of Common Stock (Direct)
  Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 21,213.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,362 shares of Common Stock at $15.47 per share (Direct)
  Date: 2026-03-31 | Code: F | equity_swap_involved: 0 | shares_owned_after: 19,941.00 | transaction_form_type: 4 | Footnotes: F3
• Acquired 5,592 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 16,779.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2, F2

Footnotes:

• F1: Restricted stock units ("RSUs") represent a contingent right to receive shares of the Issuer's common stock ("Shares") on a one-for-one basis, pursuant to the Issuer's 2024 Omnibus Equity and Incentive Plan.
• F2: On March 31, 2025, the Reporting Person was granted 22,371 RSUs, vesting in equal annual installments as to 1/4 of the RSUs on each of March 31, 2026, 2027, 2028 and 2029, subject to continued service with the Issuer through the applicable date.
• F3: Due to administrative error, the Form 4 filed by the Reporting Person with the U.S. Securities and Exchange Commission on October 7, 2025 reflected a disposition of 2,654 Shares by the Reporting Person on October 4, 2025, rather than the 2,564 Shares actually disposed of by the Reporting Person on such date (i.e., a difference of 90 Shares). This total number includes such Shares, which are still held by the Reporting Person.